Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dirk Baumann

Vascular Surgery Burlingame, CA Medical Doctor

NPI 1013058122 CMS profile 272652

1501 Trousdale Dr, 5Th Floor, Burlingame, CA 94010

Open in the dashboard

General payments

$127,347

140 records reported · program years 2019–2025

Research payments

$3,900

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dirk Baumann of Burlingame, CA is reported in the CMS Open Payments database as having received $127,347 across 140 general payments and $3,900 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,726 19
2024 General $11,933 5
2023 General $9,476 20
2022 General $25,198 14
2021 General $20,881 19
2020 General $16,499 26
2019 General $31,634 37
2019 Research $3,900 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dirk Baumann
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Dirk Baumann were reported at $11,726. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Dirk Baumann Vascular Surgery median Middle half National median
2019 $31,634 $796 $226–$2,363 $163
2020 $16,499 $348 $118–$1,110 $114
2021 $20,881 $471 $158–$1,421 $132
2022 $25,198 $725 $222–$2,183 $149
2023 $9,476 $836 $257–$2,440 $160
2024 $11,933 $909 $252–$2,619 $164
2025 $11,726 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bard Peripheral Vascular, Inc. $111,788 76 payments
  2. C. R. Bard, Inc. & Subsidiaries $7,292 5 payments
  3. Penumbra, Inc. $3,831 12 payments
  4. Inari Medical, Inc. $1,059 7 payments
  5. Stryker Corporation $1,058 6 payments
  6. Medtronic, Inc. $558 5 payments
  7. W. L. Gore & Associates, Inc. $485 6 payments
  8. Medtronic Vascular, Inc. $472 6 payments
  9. Boston Scientific Corporation $186 3 payments
  10. Janssen Pharmaceuticals, Inc $182 3 payments
  11. Other $436 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $85,046 33 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $21,000 4 payments
  3. Travel and Lodging $11,768 28 payments
  4. Food and Beverage $5,893 72 payments
  5. Honoraria $3,601 1 payment
  6. Education $39 2 payments
Products named General payments · program years 2019–2025
  1. LUTONIX BD Interventional - Peripheral Intervention $7,033 7 payments
  2. COVERA $4,714 7 payments
  3. LUTONIX Peripheral Vascular $4,669 4 payments
  4. WAVELINQ $4,669 4 payments
  5. LIFESTREAM $4,669 4 payments
  6. Indigo System $2,669 6 payments
  7. CT THROMBECTOMY SYSTEM KIT $1,594 6 payments
  8. FLOWTRIEVER CATHETER, S $1,594 6 payments
  9. RUBY Coil $1,162 6 payments
  10. LUTONIX BD Interventional Peripheral Intervention $1,100 1 payment
  11. Other $4,893 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Bard Peripheral Vascular, Inc. $3,900 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

96

Median for Vascular Surgery: 122

Drug cost

$17,119

Median for Vascular Surgery: $14,135

Branded share of claims

49%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 21 $16,184
Atorvastatin Calcium Generic 49 $603
Clopidogrel Clopidogrel Bisulfate Brand 26 $332

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 156 billing codes

Paid by Medicare

$255,305

Medicare's payments for the services billed

Medicare patients

822

Average age 77

Services billed

2,105

378 women, 444 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Chronic kidney disease 43%
Ischemic heart disease 41%
Diabetes 40%
Heart failure 32%
Atrial fibrillation 30%
Depression 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record